Internal Med Medical News about Osteoarthritis, Hip Osteoarthritis, Knee Doxycycline

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Doxycycline for osteoarthritis of the knee or hip
Cochrane Reviews, 10/23/09

Nuesch E et al. – The symptomatic benefit of doxycycline is minimal to non–existent. The small benefit in terms of joint space narrowing is of questionable clinical relevance and outweighed by safety problems. Doxycycline should not be recommended for the treatment of osteoarthritis of the knee or hip.

<< Previous
Improving Primary Care for Older Adults with Cancer and...

Next >>
Effects of liraglutide in the treatment of obesity: a randomised,...

S-Adenosylmethionine for osteoarthritis of the knee or hip
Cochrane Reviews, 10/22/09 Relevance Score: 90%

Knee and Hip Radiographic Osteoarthritis Predict Total Hip Bone Loss in Older Adults: A Prospective Study
Journal of Bone and Mineral Research, 10/16/09 Relevance Score: 90%

Correlates of Pain Intensity in Men and Women With Hip and Knee Osteoarthritis. Results of a National Survey: The French ARTHRIX Study
The Clinical Journal of Pain, 10/23/09 Relevance Score: 89%

Oral or transdermal opioids for osteoarthritis of the knee or hip
Cochrane Reviews, 10/13/09 Relevance Score: 89%

Osteoarthritis: A review of treatment options
Geriatrics, 10/21/09 Relevance Score: 88%